| Literature DB >> 31185730 |
Belinda Rivera-Lebron1, Michael McDaniel2, Kamran Ahrar3, Abdulah Alrifai4, David M Dudzinski5, Christina Fanola6, Danielle Blais7, David Janicke8, Roman Melamed9, Kerry Mohrien10, Elizabeth Rozycki7, Charles B Ross11, Andrew J Klein11, Parth Rali10, Nicholas R Teman12, Leoara Yarboro12, Eugene Ichinose13, Aditya M Sharma12, Jason A Bartos6, Mahir Elder14,15, Brent Keeling2, Harold Palevsky16, Soophia Naydenov17, Parijat Sen18, Nancy Amoroso19, Josanna M Rodriguez-Lopez5, George A Davis20, Rachel Rosovsky5, Kenneth Rosenfield5, Christopher Kabrhel5, James Horowitz19, Jay S Giri16, Victor Tapson21, Richard Channick22.
Abstract
Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity and mortality. There have been many advances in the field of PE in the last few years, requiring a careful assessment of their impact on patient care. However, variations in recommendations by different clinical guidelines, as well as lack of robust clinical trials, make clinical decisions challenging. The Pulmonary Embolism Response Team Consortium is an international association created to advance the diagnosis, treatment, and outcomes of patients with PE. In this consensus practice document, we provide a comprehensive review of the diagnosis, treatment, and follow-up of acute PE, including both clinical data and consensus opinion to provide guidance for clinicians caring for these patients.Entities:
Keywords: acute pulmonary embolism; catheter-directed thrombolysis; chronic thromboembolic pulmonary hypertension; embolectomy; inferior vena cava filter; pulmonary embolism response team; systemic thrombolysis; venous thromboembolism
Mesh：
Year: 2019 PMID： 31185730 PMCID： PMC6714903 DOI： 10.1177/1076029619853037
Source DB: PubMed Journal: Clin Appl Thromb Hemost ISSN： 1076-0296 Impact factor: 2.389